🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT07793682
Active, not recruiting Not applicable

Early Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke

NCT07793682 · tracked via the Priya Life Science Spain tracker
Sponsor
Althaia Xarxa Assistencial Universitària de Manresa
Phase
Not applicable
Started
2025-11-19
Last updated
2026-09-03

Condition(s) studied

Ischemic StrokeCognitive ImpairmentQuality of LifeCaregiver Burden

Investigational drug(s) / intervention(s)

Computerized neuropsychological rehabilitationFamily psychoeducational programNon-specific recreational cognitive activities / active digital controlWritten information leaflet

Computerized neuropsychological rehabilitation: Structured computerized cognitive training using the Guttmann NeuroPersonalTrainer platform. The intervention comprises 24 sessions of 45 minutes, delivered twice weekly over approximately 12 weeks, starting after randomization approximately 20 days after the index stroke. The sequence and duration of cognitive exercises are standardized, while task difficulty is individually adjusted by the platform according to previous performance.

Family psychoeducational program: Six individual 45-minute sessions delivered by videoconference to the primary family caregiver approximately every 2 weeks over 12 weeks. The program covers stroke education, the role of the family in recovery, emotional management, behavioral difficulties, cognitive restructuring, relaxation, self-compassion, mindfulness-based coping strategies, and behavioral activation. Caregivers are not trained in cognitive rehabilitation techniques.

Non-specific recreational cognitive activities / active digital control: Simple recreational digital activities matched to the computerized neuropsychological rehabilitation condition in session duration and frequency. The activities do not incorporate adaptive difficulty, structured therapeutic progression, or cognitive performance feedback.

Written information leaflet: A brief informational leaflet provided at the approximately 20-day visit after randomization. The leaflet includes general information about stroke and its physical, communicative, cognitive, emotional, and behavioral consequences, together with recommended educational resources. It does not include behavioral management strategies, structured psychoeducational techniques, or cognitive rehabilitation training.

Study summary

Cognitive impairment and reduced quality of life are frequent consequences of ischemic stroke and can also affect family caregivers, who often assume caregiving responsibilities with limited preparation. Evidence regarding rehabilitation interventions initiated during the early poststroke period remains limited.

This randomized clinical trial evaluates two independent interventions initiated after baseline assessment and randomization, approximately 20 days after the index stroke: a structured computerized neuropsychological rehabilitation program for the patient and a structured psychoeducational program for the primary family caregiver. A 2×2 factorial design allows the main effect of each intervention to be estimated within a single sample and permits an exploratory assessment of their interaction.

The primary outcome is quality of life at 3 months after stroke, measured using the CAVIDACE total direct score and completed by a family informant. Secondary outcomes include cognitive performance, functional status, mood, and caregiver burden. Molecular biomarkers and acute structural neuroimaging variables are examined as exploratory outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * First-ever ischemic stroke, excluding transient ischemic attack * Age 18 years or older * Inclusion within 96 hours of symptom onset * Functional independence before the index stroke, defined as a prestroke Modified Rankin Scale score ≤1 * Diagnosis of ischemic stroke classified according to the Oxfordshire Community Stroke Project as total anterior circulation infarction, partial anterior circulation infarction, posterior circulation infarction, or lacunar infarction * Capacity to provide written informed consent at enrollment or, in cases of temporary incapacity, availability of a legally authorized representative to provide consent on the participant's behalf, followed by participant re-consent if decision-making capacity is regained Exclusion Criteria: * Previous neurological or psychiatric disease associated with cognitive impairment * Severe systemic disease * Life expectancy of less than 1 year * Severe stroke, defined as a National Institutes of Health Stroke Scale score \>19 at admission * Alcohol or other substance abuse, excluding tobacco use * Clinically relevant aphasia preventing comprehension of neuropsychological test instructions, operationalized as a score \<5 on the fluency subscale of the Western Aphasia Battery * Sensory impairment preventing valid neuropsychological assessment or use of the intervention materials, such as severe visual or hearing impairment * Functional illiteracy, defined as inability to read and understand simple written instructions

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitari Sant Joan de Déu de Manresa, Fundació Althaia Manresa Barcelona

More Althaia Xarxa Assistencial Universitària de Manresa trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07793682 on ClinicalTrials.gov ↗ ← All trials in Spain